Form D · Pharmaceuticals
CORNERSTONE THERAPEUTICS INC
Cary, NC · CIK 0001145404
Offering snapshot reported Jul 3, 2012 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 21, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 3, 2012 | Initial | $30,000,000 | No comparison | 1 | SEC filing |
| Jul 5, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-180699
Convertible term loan.
Source: Form D, filed Jul 3, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher G. Codeanne | Director |
| Craig A. Collard | Director, Executive |
| Michael D. Enright | Director |
| Anton Giorgio Failla | Director |
| James A. Harper | Director |
| Michael Heffernan | Director |
| Kenneth R. Mcbean | Executive |
| Vincent T. Morgus | Executive |
| Andrew K. W. Powell | Executive |
| Alan T. Roberts | Executive |
| Laura Shawver | Director |
| Robert M. Stephan | Director |
| Marco Vecchia | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1255 Crescent Green Drive Suite 250
Cary, NC, 27518
Cary, NC, 27518